‘The Beauty’ Review: Ryan Murphy Gets His Groove Back With Graphic Sci-Fi Drama
Ryan Murphy’s been having a rough go at winning over viewers lately. His most recent shows, “Monster: The Ed Gein Story” and “All’s Fair,” flopped with critics but gathered early viewer attention before fading out. So when ads for his latest show immediately began to elicit comparisons to the 2024 award-winning film, “The Substance,” it […]
STAT+: Novo strikes deal for diabetes cell therapies
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning. We’re breaking down some of the key parts of a sweeping new health care bill today. The need-to-know this morning Johnson & Johnson kicked off the fourth-quarter earnings season with in-line profits […]
Beyond the Bald Truth: Rejecting Big Pharma’s GLP-1 Gamble for Natural, Lifelong Health
(NaturalNews) Introduction: The High Cost of Quick FixesIn the frenzied pursuit of rapid weight loss, millions have turned to GLP-1 drugs like Ozempic and Wegovy,…
STAT+: Pharmalittle: We’re reading about Canada speeding drug reviews, Novo Nordisk ads, and more
Rise and shine, everyone, another busy day is headed your way. And it is getting off to a chilly start here on the Pharmalot campus, where clear blue skies and frigid temperatures are greeting us today. This requires reheating the trusty coffee kettle for another cup of stimulation. Our choice today is peppermint mocha, a […]
A synbiotic supplement reduces body fat and increases GLP-1 secretion in a pilot clinical study
Publication date: February 2026 Source: Journal of Functional Foods, Volume 137 Author(s): Chiao-Wei Lin, Hsin-Bai Zou, Rou-An Chen, Chi-Shan Li, Chia-Ying Lin, Cheng-Chih Hsu
Amgen (AMGN) Expands Obesity Strategy With Ro Collaboration on GLP-1 Therapies
Post Content
Matthew DelMauro, MD Observes Rise in Plastic Surgery at his NYC Practice Following GLP-1-Related Weight Loss
NEW YORK, Jan. 21, 2026 /PRNewswire/ — Matthew DelMauro, MD, board-certified plastic surgeon, is reporting a noticeable increase in patients seeking plastic surgery after significant weight loss associated with GLP-1 medications. While these medications have helped many individuals…
Ozempic just released its own version of the iconic Mac vs. PC ad
Novo Nordisk’s ‘There’s Only One Ozempic’ campaign is about reasserting the drugmaker’s brand name in an increasingly competitive landscape. Ozempic-maker Novo Nordisk turned to the actors from Apple’s 2000s “Get a Mac” ads to differentiate its GLP-1 medication amid a rising sea of competitors.
Ozempic Improves Knee Replacement Outcomes Among People With Type 2 Diabetes
WEDNESDAY, Jan. 21, 2026 — Even a brief round of Ozempic can help people with type 2 diabetes have a more successful knee replacement surgery, a new study says.
Patients given Ozempic just a few months prior to their knee replacement surgery…
Efsubaglutide Alfa attenuates metabolic dysfunction‐associated steatohepatitis in mice with improvements in second harmonic generation‐derived fibrosis features
Abstract Aims Metabolic dysfunction-associated steatohepatitis (MASH) is a progressive liver disease with limited effective treatments. Glucagon-like peptide-1 receptor agonists (GLP-1RAs) have shown promise for metabolic and hepatic benefits. This study evaluated the therapeutic efficacy of Efsubaglutide Alfa, a novel long-acting GLP-1RA, in a mouse model of MASH. Materials and Methods Male C57BL/6J mice with diet-induced […]